149 related articles for article (PubMed ID: 4184585)
1. [Problems of the myeloproliferative syndrome from the pathologist's viewpoint].
Werner W
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(2):227-34. PubMed ID: 4184585
[No Abstract] [Full Text] [Related]
2. [Early diagnosis of proliferative bone-marrow diseases with radioactive iron].
Montz R; Schneider C; Treske U
Dtsch Med Wochenschr; 1972 Jun; 97(26):994-1000. PubMed ID: 5038802
[No Abstract] [Full Text] [Related]
3. [Chronic myeloproliferative diseases].
Verh Dtsch Ges Pathol; 1983; 67():214-75. PubMed ID: 6666266
[No Abstract] [Full Text] [Related]
4. Undifferentiated lymphoma with coexisting myeloproliferative disorder.
Anido V; Gilbert EF; Harley JB; Salisbury R
W V Med J; 1971 Aug; 67(8):205-9. PubMed ID: 5284432
[No Abstract] [Full Text] [Related]
5. [Problems of the myeloproliferative syndrome from the clinician's viewpoint].
Stobbe H
Folia Haematol Int Mag Klin Morphol Blutforsch; 1969; 91(2):217-26. PubMed ID: 4184584
[No Abstract] [Full Text] [Related]
6. Myelofibrosis in myeloproliferative disorders.
Srinivasan U; Talvalkar GV; Advani SH
Indian J Cancer; 1978 Sep; 15(3):37-43. PubMed ID: 294411
[No Abstract] [Full Text] [Related]
7. Proplatelet production and stromal fibrosis in myeloproliferative neoplasms.
Wilkins BS
Leuk Res; 2010 Nov; 34(11):1417-9. PubMed ID: 20701970
[No Abstract] [Full Text] [Related]
8. [Megakaryocytic myelosis--cause of "idiopathic" thrombocythemia].
Burkhardt R; Kronseder A
Fortschr Med; 1977 May; 95(19):1261-6. PubMed ID: 863367
[TBL] [Abstract][Full Text] [Related]
9. [Cytology and histology of the human bone marrow].
Burkhardt R
Hamatol Bluttransfus; 1968; 4():11-29. PubMed ID: 5245346
[No Abstract] [Full Text] [Related]
10. [Bioptic medullary findings for the formation of fibres in attended and not yet attended myeloses (author's transl)].
Hill K; Dennhardt HH
Verh Dtsch Ges Pathol; 1972; 56():587-92. PubMed ID: 4130904
[No Abstract] [Full Text] [Related]
11. Myelofibrosis with C monosomy of marrow elements in a child.
Holden JD; Garcia FU; Samuels M; Dupin C; Stallworth B; Anderson E
Am J Clin Pathol; 1971 May; 55(5):573-9. PubMed ID: 5090214
[No Abstract] [Full Text] [Related]
12. [Megakaryocytic splenomegaly within the framework of myeloproliferative diseases (on the basis of 4 cases)].
Brunetti L
Arch De Vecchi Anat Patol; 1967 Aug; 49(2):619-46. PubMed ID: 5608914
[No Abstract] [Full Text] [Related]
13. Mechanism of myelofibrosis in chronic myeloproliferative disorders.
Yonekura S
Tokai J Exp Clin Med; 1987 Sep; 12(3):141-5. PubMed ID: 3331217
[No Abstract] [Full Text] [Related]
14. Bone marrow in megakaryocytic disorders.
Burkhardt R
Hematol Oncol Clin North Am; 1988 Dec; 2(4):695-733. PubMed ID: 3065325
[TBL] [Abstract][Full Text] [Related]
15. Experimental myelosclerosis.
Takácsi-Nagy L; Juhász J
Haematologia (Budap); 1971; 5(3):283-91. PubMed ID: 5128751
[No Abstract] [Full Text] [Related]
16. Morphological studies on the bone tissue of sternum in osteomyelosclerosis, panmyelosis and chronic myeloleukosis.
Velizarov A; Valkov I
Nauchni Tr Vissh Med Inst Sofiia; 1970; 49(3):61-71. PubMed ID: 4253273
[No Abstract] [Full Text] [Related]
17. Studies on the phagocytic activity of neutrophilic leukocytes.
Brandt L
Scand J Haematol Suppl; 1967; 2():1-126. PubMed ID: 5243720
[No Abstract] [Full Text] [Related]
18. [Histoplathological contribution to the knowledges of malignant megakaryocytosis].
Pennelli N; Collavo D; Cappuzzo GM
Tumori; 1968; 54(4):291-303. PubMed ID: 5697590
[No Abstract] [Full Text] [Related]
19. [Osteomyelofibrosis as a prognostic factor in myeloproliferative diseases?].
Wehmeier A; Schneider W
Dtsch Med Wochenschr; 1993 May; 118(21):804-5. PubMed ID: 8504717
[No Abstract] [Full Text] [Related]
20. [Histological and histometrical studies on benzene-induced lesions of rat bone marrow].
Noeske K; Martens H
Virchows Arch A Pathol Pathol Anat; 1972; 355(1):50-65. PubMed ID: 4622066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
